PIII
P3 Health Partners Inc
NASDAQ: PIII · HEALTHCARE · MEDICAL CARE FACILITIES
$2.77
-1.07% today
Updated 2026-04-30
Market cap
$588.18M
P/E ratio
—
P/S ratio
0.40x
EPS (TTM)
$-45.26
Dividend yield
—
52W range
$2 – $11
Volume
0.1M
P3 Health Partners Inc (PIII) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $87.70M | $145.48M | $491.06M | — | $1.05B | $1.27B | $1.50B | $1.46B |
| Revenue growth (YoY) | — | +65.9% | +237.5% | -100.0% | — | +20.7% | +18.5% | -2.8% |
| Cost of revenue | — | $141.03M | $485.30M | — | $668.07M | $1.23B | $1.56B | $1.60B |
| Gross profit | $87.70M | $145.48M | $491.06M | — | $1.05B | $1.27B | $1.50B | $-144.32M |
| Gross margin | 100.0% | 100.0% | 100.0% | — | 100.0% | 100.0% | 100.0% | -9.9% |
| R&D | — | — | — | — | — | — | — | — |
| SG&A | $28.54M | $36.42M | $53.39M | — | $157.28M | $122.36M | $112.60M | $106.31M |
| Operating income | $-49.71M | $-39.54M | $-28.59M | — | $-1.56B | $-167.93M | $-320.66M | $-270.30M |
| Operating margin | -56.7% | -27.2% | -5.8% | — | -148.7% | -13.3% | -21.4% | -18.5% |
| EBITDA | $-49.37M | $-39.04M | $-28.08M | — | $-1.46B | $-81.07M | $-197.76M | $-186.14M |
| EBITDA margin | -56.3% | -26.8% | -5.7% | — | -139.2% | -6.4% | -13.2% | -12.8% |
| EBIT | $-49.71M | $-39.44M | $-28.88M | $-187.95M | $-1.55B | $-167.75M | $-283.82M | $-270.30M |
| Interest expense | $44235.00 | $2.53M | $2.53M | — | $11.40M | $15.98M | $22.17M | $55.03M |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-43.80M | $-41.97M | $-31.41M | — | $-270.13M | $-57.77M | $-135.85M | $-147.95M |
| Net income growth (YoY) | — | +4.2% | +25.2% | +100.0% | — | +78.6% | -135.1% | -8.9% |
| Profit margin | -49.9% | -28.8% | -6.4% | — | -25.7% | -4.6% | -9.1% | -10.1% |